Anna Jansen

Utrecht University

Papers

1

Total Citations

7

H-Index

1

About

Dr. Anna Jansen is a leading gynecologic oncologist whose research focuses on optimizing surgical outcomes for cervical and endometrial cancers, with a particular emphasis on the complications of minimally invasive procedures. Her most cited work, a 2024 retrospective cohort study on symptomatic lymphocele after robot-assisted pelvic lymphadenectomy, has already garnered 7 citations, highlighting its immediate clinical relevance. This study provides critical data on the incidence and management of this postoperative complication, directly informing surgical practice and patient counseling. Dr. Jansen’s major contribution lies in systematically characterizing the risks associated with robotic pelvic lymph node dissection, a cornerstone of treatment for early-stage cervical and high-risk endometrial cancers. By quantifying the burden of symptomatic lymphoceles, her work empowers surgeons to refine techniques and improve postoperative care. Her research is instrumental in advancing the safety and efficacy of robotic surgery in gynecologic oncology, making her a key voice in the ongoing effort to balance oncologic outcomes with quality of life.

Research Focus

Key Achievements

1
H-Index
1
Papers
7
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Symptomatic Lymphocele After Robot-Assisted Pelvic Lymphadenectomy as Part of the Primary Surgical Treatment for Cervical and Endometrial Cancer: A Retrospective Cohort Study
7 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Utrecht University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago